Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Germany- Participants:18–64 years
- Substances:Atogepant
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Germany22 clinical trials in Westerstede, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on Multiple Sclerosis treatments and disease progression, including studies evaluating novel therapies like ocrelizumab and fenebrutinib for both progressive and relapsing forms.
Studies aim to assess long-term safety and effectiveness of treatments while monitoring disease progression.
Multiple trials investigating preventive treatments for various types of migraine conditions, including menstrual migraine and medication overuse headache, using innovative compounds like atogepant and eptinezumab.
Focus on both acute treatment and prevention strategies for migraine management.
Extensive research into Major Depressive Disorder and Schizophrenia, evaluating new therapeutic approaches and long-term treatment options.
Trials explore both novel compounds and combination therapies for improved patient outcomes.
Focused studies on Alzheimer's Disease examining new treatment approaches for both early-stage disease and management of associated symptoms like agitation.
Research encompasses both disease-modifying treatments and symptom management strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.